SLS Earnings Date & Options Strategy

SELLAS Life Sciences Group, Inc. Common Stock

$11.33

November 11, 2026
39 days away

Last Updated: September 18, 2026

Expected Move for November 11, 2026 Earnings

±46.9% (±$5.31)
Implied Price Range $6.02 – $16.64
Through Expiration November 13, 2026
Near-ATM Implied Volatility 140%
30-Day Historical Volatility 74% (options pricing 1.9x normal move)

Derived from implied volatility on SLS options expiring November 13, 2026 (first expiration after the earnings report), at a $11.33 stock price. The market expects SLS to trade between $6.02 and $16.64 through that expiry — roughly a one-standard-deviation range, meaning about a 68% probability if options are priced fairly.

Options IV Analysis

Loading IV data...

Earnings Estimates

EPS Estimate (Current Qtr) $-0.08
EPS Estimate (FY) $-0.27
Revenue Growth (YoY) -0.8%

How to Trade Earnings with Options

Buy Options Strategy

Buy options when IV percentile is below 30. This means options are cheap relative to their historical pricing. As earnings approach, IV typically rises (IV expansion), increasing the value of your options even before earnings.

Sell Premium Strategy

Sell options when IV percentile is above 70. After earnings, IV crashes (IV crush), which benefits option sellers. Iron condors and credit spreads profit from this IV collapse.

Timing Tips

  • 2-3 weeks before: Best time to buy options if IV is low
  • 1 week before: IV starts rising, still okay to buy if IV < 50th percentile
  • Day of earnings: IV at peak - avoid buying, consider selling
  • After earnings: IV crushes 30-50%, sellers profit

Tradestie AI Rating

66.5
Buy
Evaluate position
View Full Analysis

Gamma Positioning

Loading gamma data...

Analyst Ratings

STRONG BUY

3 analysts

Price Target $6.83
2
1
Strong Buy Buy Hold Sell

Company Info

Company SELLAS Life Sciences Group, Inc. Common Stock
Sector Healthcare
Industry Biotechnology